Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.15 HKD
6.87 B HKD
30.06 B HKD
210.45 M
About JIANGSU HENGRUI PHARMACEUTICALS CO
Sector
Industry
Website
Headquarters
Lianyungang
Founded
1970
ISIN
CNE100006XS6
FIGI
BBG01TZLZZN9
Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.
600276, Jiangsu Hengrui Medicine Co. Ltd. - Trailing StopSSE:600276
Most traders lose money.
Why?
Precisely because rather than simplify their way of operating and be as disciplined as possible, seek solutions that are apparently very technical and professional with the help of indicators and oscillators, and put them on the chart making it very complex
600276, Jiangsu Hengrui Medicine Co. Ltd - Cup & HandleSSE:600276
Classic pattern, Cup & Handle, which in this case acts as a figure of continuation of the primary trend.
Let's take advantage of this breakout of resistance level.
Statistically as we know from our backtest based on our Entry Points, Stop Loss, Take Profit, we have a % positive realizati
600276: JiangSu HengRuiPharmaceuticals have done well in China over the long-term for many years. Given the quality of JiangSu HengRui and its perpetual growth, there is no reason why this trend should abate over the long haul. This stock is immune to a trade war, yet not immune to business cycle risks, which has caused
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1276 is 57.80 HKD — it has decreased by −2.53% in the past 24 hours. Watch JIANGSU HENGRUI PHARMACEUTICALS CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JIANGSU HENGRUI PHARMACEUTICALS CO stocks are traded under the ticker 1276.
1276 stock has risen by 0.52% compared to the previous week, the month change is a 1.40% rise, over the last year JIANGSU HENGRUI PHARMACEUTICALS CO has showed a 1.40% increase.
We've gathered analysts' opinions on JIANGSU HENGRUI PHARMACEUTICALS CO future price: according to them, 1276 price has a max estimate of 85.61 HKD and a min estimate of 53.64 HKD. Watch 1276 chart and read a more detailed JIANGSU HENGRUI PHARMACEUTICALS CO stock forecast: see what analysts think of JIANGSU HENGRUI PHARMACEUTICALS CO and suggest that you do with its stocks.
1276 reached its all-time high on May 23, 2025 with the price of 60.50 HKD, and its all-time low was 52.50 HKD and was reached on May 26, 2025. View more price dynamics on 1276 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1276 stock is 3.29% volatile and has beta coefficient of −1.71. Track JIANGSU HENGRUI PHARMACEUTICALS CO stock price on the chart and check out the list of the most volatile stocks — is JIANGSU HENGRUI PHARMACEUTICALS CO there?
Today JIANGSU HENGRUI PHARMACEUTICALS CO has the market capitalization of 379.40 B, it has decreased by −0.64% over the last week.
Yes, you can track JIANGSU HENGRUI PHARMACEUTICALS CO financials in yearly and quarterly reports right on TradingView.
JIANGSU HENGRUI PHARMACEUTICALS CO is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
1276 earnings for the last quarter are 0.32 HKD per share, whereas the estimation was 0.22 HKD resulting in a 42.75% surprise. The estimated earnings for the next quarter are 0.15 HKD per share. See more details about JIANGSU HENGRUI PHARMACEUTICALS CO earnings.
JIANGSU HENGRUI PHARMACEUTICALS CO revenue for the last quarter amounts to 7.69 B HKD, despite the estimated figure of 6.81 B HKD. In the next quarter, revenue is expected to reach 7.28 B HKD.
1276 net income for the last quarter is 2.00 B HKD, while the quarter before that showed 1.86 B HKD of net income which accounts for 7.91% change. Track more JIANGSU HENGRUI PHARMACEUTICALS CO financial stats to get the full picture.
No, 1276 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 14, 2025, the company has 20.24 K employees. See our rating of the largest employees — is JIANGSU HENGRUI PHARMACEUTICALS CO on this list?
Like other stocks, 1276 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU HENGRUI PHARMACEUTICALS CO stock right from TradingView charts — choose your broker and connect to your account.